Skip to main content
See every side of every news story
Published loading...Updated

Louisiana state insurance plans spend $200 million a year on GLP-1 drugs

KEY TAKEAWAYS: State spends $200M yearly on GLP-1 drugs Coverage for obesity treatment with Ozempic not allowed Lawmakers debate using cheaper compounded versions despite FDA concerns Contracts approved with new pharmacy benefit managers for transparency Expenses have surged for Louisiana‘s public worker health insurance plans as more people are prescribed GLP-1 drugs, known by brand names such as Ozempic and Mounjaro. The diabetes drugs a…

Bias Distribution

  • 67% of the sources lean Left
67% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Louisiana Illuminator broke the news in on Friday, September 19, 2025.
Sources are mostly out of (0)

Similar News Topics

News
For You
Search
BlindspotLocal